Quicklinks
About The Pharmacogenomics Centre
The Beaulieu-Saucier Université de Montréal Pharmacogenomics Centre, was formed in 2006 as a partnership between Université de Montréal, the Montreal Heart Institute and Génome Québec. Located in Montreal, Canada and employing over 25 people, the Centre has received more than $20M in funding since its inception. In June 2008, the Pharmacogenomics Centre moved into its new facilities, the Université de Montréal Beaulieu-Saucier Pharmacogenomics Centre, located at the Montreal Heart Institute.
The Pharmacogenomics Centre and its partners provide expertise in pharmacogenomic and clinical genetic research (including statistical genetics, ethical, legal, social and pharmaco-economics issues), pharmacology, and proteomics.
Through its technology and development platforms, the Pharmacogenomics Centre provides opportunities to expand and enhance existing research programs through the inclusion of genetic information at all phases of drug development.
We provide a full range of services on a variety of platforms to the academic, research and pharmaceutical sectors, including DNA isolation and biobanking, SNP genotyping, genome-wide association analysis, custom SNP panel development, and statistical genetics. The Pharmacogenomics Centre operates in a GLP environment, ensuring the highest quality data.
